Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

WIN 2016

27 - 28 Jun 2016

Hotel Novotel Paris Eiffel Tower, Paris, France

Monitoring the cancer genome in plasma using circulating tumour DNA

Dr Nitzan Rosenfeld - Cancer Research UK Cambridge Institute, Cambridge, UK

Monitoring the cancer genome in plasma using circulating tumour DNA ( Dr Nitzan Rosenfeld - Cancer Research UK Cambridge Institute, Cambridge, UK )

Models and critical preclinical data shaping personal therapy

Prof Brian Leyland-Jones - Avera McKennan Cancer Institute, Sioux-Falls, USA

Models and critical preclinical data shaping personal therapy ( Prof Brian Leyland-Jones - Avera McKennan Cancer Institute, Sioux-Falls, USA )

Cancer organoids

Dr Robert Vries - Hubrecht Organoid Technology, Utrecht, The Netherlands

Cancer organoids ( Dr Robert Vries - Hubrecht Organoid Technology, Utrecht, The Netherlands )

Serum miRNAs as diagnostic tools in GI malignancies

Dr Ajay Goel - Baylor University Medical Center, Waco, USA

Serum miRNAs as diagnostic tools in GI malignancies ( Dr Ajay Goel - Baylor University Medical Center, Waco, USA )

Combination trial designs: efficient, effective and tolerable regimens

Dr Susan Galbraith – AstraZeneca, Macclesfield, UK

Combination trial designs: efficient, effective and tolerable regimens ( Dr Susan Galbraith – AstraZeneca, Macclesfield, UK )

Patient perspectives in precision medicine: 'No innovation about us without us'

Dr Francesco de Lorenzo - European Cancer Patient Coalition, Brussels, Belgium

Patient perspectives in precision medicine: 'No innovation about us without us' ( Dr Francesco de Lorenzo - European Cancer Patient Coalition, Brussels, Belgium )

Liquid biopsies to track clonal evolution and resistance in mCRC

Dr Alberto Bardelli - Candiolo Cancer Institute, Turin, Italy

Liquid biopsies to track clonal evolution and resistance in mCRC ( Dr Alberto Bardelli - Candiolo Cancer Institute, Turin, Italy )

Preclinical strategies for precision medicine in colorectal cancer

Dr Livio Trusolino - Candiolo Cancer Institute, Turin, Italy

Preclinical strategies for precision medicine in colorectal cancer ( Dr Livio Trusolino - Candiolo Cancer Institute, Turin, Italy )

WIN 2016 highlights: Emerging technologies

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

WIN 2016 highlights: Emerging technologies ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )

Critique of the SHIVA trial

Dr Razelle Kurzrock - University of California, San Diego, USA

Critique of the SHIVA trial ( Dr Razelle Kurzrock - University of California, San Diego, USA )

SURVIVEiT supporting patient engagement and care

Matt Ellefson - Founder/CEO, SURVIVEiT, USA

SURVIVEiT supporting patient engagement and care ( Matt Ellefson - Founder/CEO, SURVIVEiT, USA )

Personalising breast cancer therapy

Dr Funda Meric-Bernstam - University of Texas MD Anderson Cancer Center, Houston, USA

Personalising breast cancer therapy ( Dr Funda Meric-Bernstam - University of Texas MD Anderson Cancer Center, Houston, USA )

Affordable next generation sequencing to support decision making

Dr Elaine Mardis - Washington University, St Louis, USA

Affordable next generation sequencing to support decision making ( Dr Elaine Mardis - Washington University, St Louis, USA )

Characterisation of somatic mutations using patient RNASeq profiles

Prof Andrea Califano - Columbia University Medical Center, New York, USA

Characterisation of somatic mutations using patient RNASeq profiles ( Prof Andrea Califano - Columbia University Medical Center, New York, USA )

WIN 2016 highlights: Changing the understanding of cancer

Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO)

WIN 2016 highlights: Changing the understanding of cancer ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )

Results of the MINDACT clinical trial

Dr Suzette Delaloge - Institut Gustave Roussy, Paris, France

Results of the MINDACT clinical trial ( Dr Suzette Delaloge - Institut Gustave Roussy, Paris, France )

Systems thinking in the future of personalised medicine

Prof Leroy Hood - Systems Biology, Seattle, USA

Systems thinking in the future of personalised medicine ( Prof Leroy Hood - Systems Biology, Seattle, USA )

Precision cancer medicine in Korea

Dr Chang-Sik Yu - ASAN Medical Center, Seoul, Korea

Precision cancer medicine in Korea ( Dr Chang-Sik Yu - ASAN Medical Center, Seoul, Korea )

New targets in personalised therapy for patients with lung cancer

Prof Bruce Johnson - Dana-Farber Cancer Institute, Bethesda, USA

New targets in personalised therapy for patients with lung cancer ( Prof Bruce Johnson - Dana-Farber Cancer Institute, Bethesda, USA )

WIN 2016: Preview of themes

Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

WIN 2016: Preview of themes ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )

WIN 2016: Preview of Speakers

Dr John Mendelsohn - Chairman of the WIN Consortium

WIN 2016: Preview of Speakers ( Dr John Mendelsohn - Chairman of the WIN Consortium )

More from ecancer